Vipoglanstat

DRUG2 trials

Sponsors

Gesynta Pharma AB

Conditions

EndometriosisEndometriosis related pain

Phase 2

A Phase 2, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of 2 doses of vipoglanstat in patients with moderate to severe endometriosis-related pain – the NOVA trial

Not yet recruitingCTIS2025-522452-16-00

Gesynta Pharma ABEndometriosis related pain

Target: 213Updated: 2026-01-26

A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis

RecruitingNCT07260669

Gesynta Pharma ABEndometriosis

Start: 2025-10-15End: 2027-06-01Target: 190Updated: 2026-09-11